See how making the shift to disposable ureteroscopes, like BD Aptra™ Ureteroscope, has made a difference for Dr. Stoller, MD Professor and Vice Chair of Urology.
The BD Aptra™ Ureteroscope is our answer to the natural evolution of ureteroscopy: a single-use device combining essential visualization, increased functionality, and comfort. Without the unnecessary variabilities of reusable ureteroscopes—from unpredictable downtime and expensive repairs to diminishing performance and lifecycles. The BD Aptra™ Ureteroscope provides a responsive solution to meet the demands associated with increasing case numbers.
BD Aptra™—Championing single-use adoption, because it's the smart and responsible thing to do
See how making the shift to disposable ureteroscopes, like BD Aptra™ Ureteroscope, has made a difference for Dr. Stoller, MD Professor and Vice Chair of Urology.
The BD Aptra™ Ureteroscope offers:
GTIN - each
00850023925015
1
Voltage
AC 100-240V
Frequency
50/60 Hz
Video output
CVBS/HDMI output to monitor
Dimensions
34.5 cm x 8.8 cm x 36.0 cm width x height x depth
Weight
3.2 kg
GTIN - each | 00850023925015 | 1 |
Voltage | AC 100-240V |
Frequency | 50/60 Hz |
Video output | CVBS/HDMI output to monitor |
Dimensions | 34.5 cm x 8.8 cm x 36.0 cm width x height x depth |
Weight | 3.2 kg |
BD offers training resources to help improve your clinical practices as part of our goal of advancing the world of health.
BD supports the healthcare industry with market-leading products and services that aim to improve care while lowering costs. We host and take part in events that excel in advancing the world of health™.
BD promotes clinical excellence by providing various resources on best practices, clinical innovations and industry trends in healthcare.
If you are a patient or end user, you can contact us yourself, or you may have your caregiver or your physician do that for you. To help us process your
information quickly and effectively, please contact our customer complaints
team.
To better facilitate our investigation, please include the following information in your reporting: